Selected research
Market Structure
Global AI Drug Safety Prediction Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Drug Safety Prediction Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Drug Safety Prediction Software include Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, Insilico Medicine and MindRank, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Drug Safety Prediction Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Drug Safety Prediction Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Drug Safety Prediction Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Drug Safety Prediction Software market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Drug Safety Prediction Software Segment by Company
Certara
Lhasa Limited
Instem
ACD/Labs
Chemical Computing Group
Optibrium
MultiCASE
Insilico Medicine
MindRank
Molecular Discovery
Molecular Networks
OASIS LMC
Simulations Plus
Dassault Systèmes
Schrödinger
AI Drug Safety Prediction Software Segment by Type
Integrated ADMET Prediction
Toxicity Endpoint Prediction
Drug-Drug Interaction and PK Safety Prediction
Metabolism and Metabolite Prediction
Off-Target and Safety Pharmacology Prediction
AI Drug Safety Prediction Software Segment by Application
Hit and Lead Screening
Lead Optimization
Candidate Selection
Preclinical Safety Assessment
Regulatory Safety Assessment
Other Drug Safety Research
AI Drug Safety Prediction Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Safety Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Safety Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Safety Prediction Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Drug Safety Prediction Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Safety Prediction Software industry.
Chapter 3: Detailed analysis of AI Drug Safety Prediction Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Safety Prediction Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Integrated ADMET Prediction
- Toxicity Endpoint Prediction
- Drug-Drug Interaction and PK Safety Prediction
- Metabolism and Metabolite Prediction
- Off-Target and Safety Pharmacology Prediction
Applications
- Hit and Lead Screening
- Lead Optimization
- Candidate Selection
- Preclinical Safety Assessment
- Regulatory Safety Assessment
- Other Drug Safety Research
Companies covered
- Certara
- Lhasa Limited
- Instem
- ACD/Labs
- Chemical Computing Group
- Optibrium
- MultiCASE
- Insilico Medicine
- MindRank
- Molecular Discovery
- Molecular Networks
- OASIS LMC
- Simulations Plus
- Dassault Systèmes
- Schrödinger
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Drug Safety Prediction Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Integrated ADMET Prediction
- 1.2.3 Toxicity Endpoint Prediction
- 1.2.4 Drug-Drug Interaction and PK Safety Prediction
- 1.2.5 Metabolism and Metabolite Prediction
- 1.2.6 Off-Target and Safety Pharmacology Prediction
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Drug Safety Prediction Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hit and Lead Screening
- 1.3.3 Lead Optimization
- 1.3.4 Candidate Selection
- 1.3.5 Preclinical Safety Assessment
- 1.3.6 Regulatory Safety Assessment
- 1.3.7 Other Drug Safety Research
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Drug Safety Prediction Software Growth Trends by Region
- 1.5.1 Global AI Drug Safety Prediction Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Drug Safety Prediction Software Market Size by Region (2021-2026)
- 1.5.3 AI Drug Safety Prediction Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Drug Safety Prediction Software Market Dynamics
- 2.1 AI Drug Safety Prediction Software Industry Trends
- 2.2 AI Drug Safety Prediction Software Industry Drivers
- 2.3 AI Drug Safety Prediction Software Industry Opportunities and Challenges
- 2.4 AI Drug Safety Prediction Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Drug Safety Prediction Software Revenue by Company (2021-2026)
- 3.2 Global AI Drug Safety Prediction Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Drug Safety Prediction Software Key Company Head office and Area Served
- 3.4 Global AI Drug Safety Prediction Software Company, Product Type & Application
- 3.5 Global AI Drug Safety Prediction Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Drug Safety Prediction Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Drug Safety Prediction Software Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Drug Safety Prediction Software Tier 1, Tier 2, and Tier 3
4 AI Drug Safety Prediction Software Market by Type
- 4.1 Global AI Drug Safety Prediction Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Drug Safety Prediction Software Market Size by Type (2021-2032)
- 4.3 Global AI Drug Safety Prediction Software Market Size Share by Type (2021-2032)
5 AI Drug Safety Prediction Software Market by Application
- 5.1 Global AI Drug Safety Prediction Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Drug Safety Prediction Software Market Size by Application (2021-2032)
- 5.3 Global AI Drug Safety Prediction Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Certara
- 6.1.1 Certara Company Information
- 6.1.2 Certara Business Overview
- 6.1.3 Certara AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Certara AI Drug Safety Prediction Software Product Portfolio
- 6.1.5 Certara Recent Developments
- 6.2 Lhasa Limited
- 6.2.1 Lhasa Limited Company Information
- 6.2.2 Lhasa Limited Business Overview
- 6.2.3 Lhasa Limited AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Lhasa Limited AI Drug Safety Prediction Software Product Portfolio
- 6.2.5 Lhasa Limited Recent Developments
- 6.3 Instem
- 6.3.1 Instem Company Information
- 6.3.2 Instem Business Overview
- 6.3.3 Instem AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Instem AI Drug Safety Prediction Software Product Portfolio
- 6.3.5 Instem Recent Developments
- 6.4 ACD/Labs
- 6.4.1 ACD/Labs Company Information
- 6.4.2 ACD/Labs Business Overview
- 6.4.3 ACD/Labs AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 ACD/Labs AI Drug Safety Prediction Software Product Portfolio
- 6.4.5 ACD/Labs Recent Developments
- 6.5 Chemical Computing Group
- 6.5.1 Chemical Computing Group Company Information
- 6.5.2 Chemical Computing Group Business Overview
- 6.5.3 Chemical Computing Group AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio
- 6.5.5 Chemical Computing Group Recent Developments
- 6.6 Optibrium
- 6.6.1 Optibrium Company Information
- 6.6.2 Optibrium Business Overview
- 6.6.3 Optibrium AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Optibrium AI Drug Safety Prediction Software Product Portfolio
- 6.6.5 Optibrium Recent Developments
- 6.7 MultiCASE
- 6.7.1 MultiCASE Company Information
- 6.7.2 MultiCASE Business Overview
- 6.7.3 MultiCASE AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 MultiCASE AI Drug Safety Prediction Software Product Portfolio
- 6.7.5 MultiCASE Recent Developments
- 6.8 Insilico Medicine
- 6.8.1 Insilico Medicine Company Information
- 6.8.2 Insilico Medicine Business Overview
- 6.8.3 Insilico Medicine AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Insilico Medicine AI Drug Safety Prediction Software Product Portfolio
- 6.8.5 Insilico Medicine Recent Developments
- 6.9 MindRank
- 6.9.1 MindRank Company Information
- 6.9.2 MindRank Business Overview
- 6.9.3 MindRank AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 MindRank AI Drug Safety Prediction Software Product Portfolio
- 6.9.5 MindRank Recent Developments
- 6.10 Molecular Discovery
- 6.10.1 Molecular Discovery Company Information
- 6.10.2 Molecular Discovery Business Overview
- 6.10.3 Molecular Discovery AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Molecular Discovery AI Drug Safety Prediction Software Product Portfolio
- 6.10.5 Molecular Discovery Recent Developments
- 6.11 Molecular Networks
- 6.11.1 Molecular Networks Company Information
- 6.11.2 Molecular Networks Business Overview
- 6.11.3 Molecular Networks AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Molecular Networks AI Drug Safety Prediction Software Product Portfolio
- 6.11.5 Molecular Networks Recent Developments
- 6.12 OASIS LMC
- 6.12.1 OASIS LMC Company Information
- 6.12.2 OASIS LMC Business Overview
- 6.12.3 OASIS LMC AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 OASIS LMC AI Drug Safety Prediction Software Product Portfolio
- 6.12.5 OASIS LMC Recent Developments
- 6.13 Simulations Plus
- 6.13.1 Simulations Plus Company Information
- 6.13.2 Simulations Plus Business Overview
- 6.13.3 Simulations Plus AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Simulations Plus AI Drug Safety Prediction Software Product Portfolio
- 6.13.5 Simulations Plus Recent Developments
- 6.14 Dassault Systèmes
- 6.14.1 Dassault Systèmes Company Information
- 6.14.2 Dassault Systèmes Business Overview
- 6.14.3 Dassault Systèmes AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio
- 6.14.5 Dassault Systèmes Recent Developments
- 6.15 Schrödinger
- 6.15.1 Schrödinger Company Information
- 6.15.2 Schrödinger Business Overview
- 6.15.3 Schrödinger AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Schrödinger AI Drug Safety Prediction Software Product Portfolio
- 6.15.5 Schrödinger Recent Developments
7 North America
- 7.1 North America AI Drug Safety Prediction Software Market Size (2021-2032)
- 7.2 North America AI Drug Safety Prediction Software Market Size by Type
- 7.2.1 North America AI Drug Safety Prediction Software Market Size by Type (2021-2026)
- 7.2.2 North America AI Drug Safety Prediction Software Market Size by Type (2027-2032)
- 7.2.3 North America AI Drug Safety Prediction Software Market Share by Type (2021-2032)
- 7.3 North America AI Drug Safety Prediction Software Market Size by Application
- 7.3.1 North America AI Drug Safety Prediction Software Market Size by Application (2021-2026)
- 7.3.2 North America AI Drug Safety Prediction Software Market Size by Application (2027-2032)
- 7.3.3 North America AI Drug Safety Prediction Software Market Share by Application (2021-2032)
- 7.4 North America AI Drug Safety Prediction Software Market Size by Country
- 7.4.1 North America AI Drug Safety Prediction Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 7.4.3 North America AI Drug Safety Prediction Software Market Size by Country (2027-2032)
- 7.4.4 North America AI Drug Safety Prediction Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Drug Safety Prediction Software Market Size (2021-2032)
- 8.2 Europe AI Drug Safety Prediction Software Market Size by Type
- 8.2.1 Europe AI Drug Safety Prediction Software Market Size by Type (2021-2026)
- 8.2.2 Europe AI Drug Safety Prediction Software Market Size by Type (2027-2032)
- 8.2.3 Europe AI Drug Safety Prediction Software Market Share by Type (2021-2032)
- 8.3 Europe AI Drug Safety Prediction Software Market Size by Application
- 8.3.1 Europe AI Drug Safety Prediction Software Market Size by Application (2021-2026)
- 8.3.2 Europe AI Drug Safety Prediction Software Market Size by Application (2027-2032)
- 8.3.3 Europe AI Drug Safety Prediction Software Market Share by Application (2021-2032)
- 8.4 Europe AI Drug Safety Prediction Software Market Size by Country
- 8.4.1 Europe AI Drug Safety Prediction Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 8.4.3 Europe AI Drug Safety Prediction Software Market Size by Country (2027-2032)
- 8.4.4 Europe AI Drug Safety Prediction Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Drug Safety Prediction Software Market Size (2021-2032)
- 9.2 China AI Drug Safety Prediction Software Market Size by Type
- 9.2.1 China AI Drug Safety Prediction Software Market Size by Type (2021-2026)
- 9.2.2 China AI Drug Safety Prediction Software Market Size by Type (2027-2032)
- 9.2.3 China AI Drug Safety Prediction Software Market Share by Type (2021-2032)
- 9.3 China AI Drug Safety Prediction Software Market Size by Application
- 9.3.1 China AI Drug Safety Prediction Software Market Size by Application (2021-2026)
- 9.3.2 China AI Drug Safety Prediction Software Market Size by Application (2027-2032)
- 9.3.3 China AI Drug Safety Prediction Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Drug Safety Prediction Software Market Size (2021-2032)
- 10.2 Asia AI Drug Safety Prediction Software Market Size by Type
- 10.2.1 Asia AI Drug Safety Prediction Software Market Size by Type (2021-2026)
- 10.2.2 Asia AI Drug Safety Prediction Software Market Size by Type (2027-2032)
- 10.2.3 Asia AI Drug Safety Prediction Software Market Share by Type (2021-2032)
- 10.3 Asia AI Drug Safety Prediction Software Market Size by Application
- 10.3.1 Asia AI Drug Safety Prediction Software Market Size by Application (2021-2026)
- 10.3.2 Asia AI Drug Safety Prediction Software Market Size by Application (2027-2032)
- 10.3.3 Asia AI Drug Safety Prediction Software Market Share by Application (2021-2032)
- 10.4 Asia AI Drug Safety Prediction Software Market Size by Country
- 10.4.1 Asia AI Drug Safety Prediction Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 10.4.3 Asia AI Drug Safety Prediction Software Market Size by Country (2027-2032)
- 10.4.4 Asia AI Drug Safety Prediction Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Drug Safety Prediction Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Drug Safety Prediction Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Drug Safety Prediction Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Drug Safety Prediction Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst